Cargando…
Correlations between comorbidities in trials and the community: An individual-level participant data meta-analysis
BACKGROUND: People with comorbidities are under-represented in randomised controlled trials, and it is unknown whether patterns of comorbidity are similar in trials and the community. METHODS: Individual-level participant data were obtained for 83 clinical trials (54,688 participants) for 16 index c...
Autores principales: | Crowther, Jamie, Butterly, Elaine W, Hannigan, Laurie J, Guthrie, Bruce, Wild, Sarah H, Mair, Frances S, Hanlon, Peter, Chadwick, Fergus J, McAllister, David A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10637135/ https://www.ncbi.nlm.nih.gov/pubmed/37953975 http://dx.doi.org/10.1177/26335565231213571 |
Ejemplares similares
-
Treatment effect modification due to comorbidity: Individual participant data meta-analyses of 120 randomised controlled trials
por: Hanlon, Peter, et al.
Publicado: (2023) -
Comorbidity and health-related quality of life in people with a chronic medical condition in randomised clinical trials: An individual participant data meta-analysis
por: Butterly, Elaine W., et al.
Publicado: (2023) -
Representation of people with comorbidity and multimorbidity in clinical trials of novel drug therapies: an individual-level participant data analysis
por: Hanlon, Peter, et al.
Publicado: (2019) -
Assessing trial representativeness using serious adverse events: an observational analysis using aggregate and individual-level data from clinical trials and routine healthcare data
por: Hanlon, Peter, et al.
Publicado: (2022) -
Identifying frailty in trials: an analysis of individual participant data from trials of novel pharmacological interventions
por: Hanlon, Peter, et al.
Publicado: (2020)